Research and Development
Novartis says Phase II data for rare lung cancer showed overall response rate of 63%
June 7, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ASCO, Novartis, Tafinlar, drug trial, lung cancer, mekinist
Pivotal avelumab data in Merkel cell carcinoma presented at ASCO
June 6, 2016 Manufacturing and Production, Research and Development ASCO, Merck, Pfizer, avelumab, merkel cell carcinoma
AbbVie says Stemcentrx’ lung cancer drug shows some benefits in early trials
June 6, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ASCO, AbbVie, Stemcentrx, drug trial, lung cancer, rova-t
AbbVie says Stemcentrx’ stem cell drug shows some benefits in early trials
June 6, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ASCO, AbbVie, Stemcentrx, drug trial, lung cancer, rova-t
Mylan’s breast cancer biosimilar matches Roche’s Herceptin in Phase III trial
June 6, 2016 Research and Development ASCO, Biocon, Herceptin, Mylan, Roche, biosimilar, breast cancer, trastuzumab
Weekly Movers: Relypsa, Titan Pharma, Allergan…
June 6, 2016 Research and Development, Sales and Marketing Stock, drug trial, research, stock market
Trial data shows promise for Lilly/MSD combo regimen in lung cancer
June 6, 2016 Research and Development, Sales and Marketing MSD, Merck, collaboration, immuno-oncology, lilly, lung cancer, non-small cell, parternship
Bristol-Myers Squibb presents Opdivo data at ASCO
June 6, 2016 Research and Development, Sales and Marketing ASCO, Bristol-Myers Squibb, opdivo
Janssen says combination Phase III study for immunotherapy Darzalex for multiple myeloma shows significant PFS
June 6, 2016 Research and Development, Sales and Marketing ASCO, Drig Trial, Janssen, multiple myeloma
Roche says Phase III trials for giant cell arteritis drug met primary endpoint
June 6, 2016 Research and Development, Sales and Marketing Roche, arthritis, drug trial
Sanofi and Regeneron combo shows superiority in late-stage atopic dermatitis trials
June 6, 2016 Research and Development, Sales and Marketing Dupilumab, Regeneron, Sanofi, atopic dermatitis, late stage trials
Novo Nordisk presents positive long-term results for Saxenda
June 3, 2016 Medical Communications, Research and Development Novo Nordisk, cardiometabolic risk factors, liraglutide, saxenda, weight loss
Shire completes Baxalta takeover
June 3, 2016 Medical Communications, Research and Development, Sales and Marketing Baxalta, Shire, deal, merger and acquisition, revenue, sales
Bayer, Orion to start Phase III trials for prostate cancer drug
June 3, 2016 Medical Communications, Research and Development, Sales and Marketing Bayer, drug trial, orion, prostate cancer, research
New FDA expanded access guidelines spell trouble for Sarepta
June 2, 2016 Medical Communications, Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, Eteplirsen, FDA, compassionate grounds, sarepta
